Literature DB >> 2204502

Selective IgG subclass deficiency: quantification and clinical relevance.

R Jefferis1, D S Kumararatne.   

Abstract

Each of the four human IgG subclasses exhibits a unique profile of effector functions relevant to the clearance and elimination of infecting microorganisms. The quantitative response within each IgG subclass varies with the nature of the antigen, its route of entry and, presumably, the form in which it is presented to the immune system. This results in antibody responses to certain antigens being predominantly or exclusively of a single IgG subclass. An inability to produce antibody of the optimally protective isotype can result in a selective immunodeficiency state. This is particularly apparent for responses to certain bacterial carbohydrate antigens that are normally of IgG2 isotype. A failure to produce the appropriate specific antibody response may result in recurrent upper and/or lower respiratory tract infection. Careful patient investigation can identify such deficiencies and suggest appropriate clinical management. In this review we outline the biology and clinical relevance of the IgG subclasses and summarize current rational treatment approaches.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2204502      PMCID: PMC1534990          DOI: 10.1111/j.1365-2249.1990.tb05339.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  87 in total

1.  Isotype concentrations of human antibodies to group A meningococcal polysaccharide.

Authors:  N Rautonen; J Pelkonen; S Sipinen; H Käyhty; O Mäkelä
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

2.  Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide.

Authors:  R B Fick; J Olchowski; S U Squier; W W Merrill; H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1986-03

3.  Serum IgG subclasses in normal adults.

Authors:  M French
Journal:  Monogr Allergy       Date:  1986

Review 4.  Immunoglobulin genes.

Authors:  T Honjo
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

5.  Monoclonal antibody-based solid-phase immunoenzymometric assays for quantifying human immunoglobulin G and its subclasses in serum.

Authors:  C Papadea; I J Check; C B Reimer
Journal:  Clin Chem       Date:  1985-12       Impact factor: 8.327

6.  Immunoglobulin G (IgG) and IgA subclass pattern of human antibodies to Shigella flexneri and Salmonella serogroup B and D lipopolysaccharide O antigens.

Authors:  M A Persson; E Ekwall; L Hammarström; A A Lindberg; C I Smith
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

7.  Correlation of serum immunoglobulin subclass concentrations with antibody responses of children to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine.

Authors:  P G Shackelford; D M Granoff; M H Nahm; M G Scott; B Suarez; S J Nelson
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

8.  Failure of therapy in pseudomonas endocarditis: selection of resistant mutants.

Authors:  V E Jimenez-Lucho; L D Saravolatz; A A Medeiros; D Pohlod
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

9.  Prospects for prevention of Haemophilus influenzae type b disease by immunization.

Authors:  D M Granoff; R S Munson
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

10.  Functional activity of different IgG subclass antibodies against type b capsular polysaccharide of Haemophilus influenzae.

Authors:  G A Weinberg; D M Granoff; M H Nahm; P G Shackelford
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

View more
  68 in total

1.  Concurrent binding to multiple ligands: kinetic rates of CD16b for membrane-bound IgG1 and IgG2.

Authors:  T E Williams; P Selvaraj; C Zhu
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

Review 2.  The antigenic properties of bacterial DNA in normal and aberrant immunity.

Authors:  D S Pisetsky
Journal:  Springer Semin Immunopathol       Date:  2000

3.  Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function.

Authors:  J E Salmon; J C Edberg; N L Brogle; R P Kimberly
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

4.  Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations.

Authors:  Oivind Torkildsen; Egil Utsi; Svein Ivar Mellgren; Hanne F Harbo; Christian A Vedeler; Kjell-Morten Myhr
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

5.  IgG subclasses in the serum and sputum from patients with bronchiectasis.

Authors:  S L Hill; J L Mitchell; D Burnett; R A Stockley
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

6.  A family of selective immunodeficiency with normal immunoglobulins: possible autosomal dominant inheritance.

Authors:  S Higuchi; H Awata; H Nunoi; H Tsuchiya; H Naoe; H Igarashi; I Matsuda
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

Review 7.  Intravenous immune globulin in primary immunodeficiency.

Authors:  M Haeney
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

8.  Successful intravenous immunoglobulin therapy for recurrent pneumococcal otitis media in young children.

Authors:  A Ishizaka; Y Sakiyama; M Otsu; K Ozutsumi; S Matsumoto
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

9.  Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass.

Authors:  R R Taylor; D B Smith; V J Robinson; J S McBride; E M Riley
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

10.  Immunoglobulin G subisotype responses of pneumonic and healthy, exposed foals and adult horses to Rhodococcus equi virulence-associated proteins.

Authors:  Kathleen E Hooper-McGrevy; Bruce N Wilkie; John F Prescott
Journal:  Clin Diagn Lab Immunol       Date:  2003-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.